Mathilde Bayet‐Robert

912 total citations
14 papers, 727 citations indexed

About

Mathilde Bayet‐Robert is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mathilde Bayet‐Robert has authored 14 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Mathilde Bayet‐Robert's work include Cancer Treatment and Pharmacology (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Mathilde Bayet‐Robert is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Mathilde Bayet‐Robert collaborates with scholars based in France, Italy and Iran. Mathilde Bayet‐Robert's co-authors include Chantal Barthomeuf, P. Chollet, Daniel Morvan, Catherine Abrial, Xavier Durando, E. Planchat, Marianne Leheurteur, Marie‐Ange Mouret‐Reynier, Émilie Thivat and Laurent Guy and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Mathilde Bayet‐Robert

14 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathilde Bayet‐Robert France 11 406 291 125 112 98 14 727
Stewart Sale United Kingdom 11 469 1.2× 235 0.8× 117 0.9× 73 0.7× 133 1.4× 16 839
Aisha Shafayat United Kingdom 5 561 1.4× 784 2.7× 116 0.9× 82 0.7× 221 2.3× 6 1.1k
Qianmei Zhou China 18 585 1.4× 119 0.4× 134 1.1× 177 1.6× 183 1.9× 45 1.0k
Yiqun Xia China 17 509 1.3× 163 0.6× 75 0.6× 112 1.0× 56 0.6× 25 771
Lokesh Dalasanur Nagaprashantha United States 15 581 1.4× 53 0.2× 164 1.3× 115 1.0× 65 0.7× 23 961
Hong‐Mei An China 15 409 1.0× 67 0.2× 78 0.6× 116 1.0× 95 1.0× 43 707
Jung Ho Back United States 10 619 1.5× 60 0.2× 168 1.3× 95 0.8× 58 0.6× 10 1.2k
Balakrishnan Solaimuthu India 11 349 0.9× 74 0.3× 120 1.0× 120 1.1× 56 0.6× 22 706

Countries citing papers authored by Mathilde Bayet‐Robert

Since Specialization
Citations

This map shows the geographic impact of Mathilde Bayet‐Robert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Bayet‐Robert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Bayet‐Robert more than expected).

Fields of papers citing papers by Mathilde Bayet‐Robert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathilde Bayet‐Robert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Bayet‐Robert. The network helps show where Mathilde Bayet‐Robert may publish in the future.

Co-authorship network of co-authors of Mathilde Bayet‐Robert

This figure shows the co-authorship network connecting the top 25 collaborators of Mathilde Bayet‐Robert. A scholar is included among the top collaborators of Mathilde Bayet‐Robert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathilde Bayet‐Robert. Mathilde Bayet‐Robert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mahammedi, Hakim, E. Planchat, Xavier Durando, et al.. (2016). The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study. Oncology. 90(2). 69–78. 112 indexed citations
2.
Ferrier, Jérémy, Mathilde Bayet‐Robert, Abderrahim El Guerrab, et al.. (2015). Cholinergic Neurotransmission in the Posterior Insular Cortex Is Altered in Preclinical Models of Neuropathic Pain: Key Role of Muscarinic M2 Receptors in Donepezil-Induced Antinociception. Journal of Neuroscience. 35(50). 16418–16430. 46 indexed citations
3.
Iranshahi, Mehrdad, Chantal Barthomeuf, Mathilde Bayet‐Robert, et al.. (2014). Drimane-type Sesquiterpene Coumarins from Ferula gummosa Fruits Enhance Doxorubicin Uptake in Doxorubicin-resistant Human Breast Cancer Cell Line. Journal of Traditional and Complementary Medicine. 4(2). 118–125. 37 indexed citations
4.
Bayet‐Robert, Mathilde & Daniel Morvan. (2013). Metabolomics Reveals Metabolic Targets and Biphasic Responses in Breast Cancer Cells Treated by Curcumin Alone and in Association with Docetaxel. PLoS ONE. 8(3). e57971–e57971. 52 indexed citations
5.
Ferrier, Jérémy, Mathilde Bayet‐Robert, Bruno Pereira, et al.. (2013). A Polyamine-Deficient Diet Prevents Oxaliplatin-Induced Acute Cold and Mechanical Hypersensitivity in Rats. PLoS ONE. 8(10). e77828–e77828. 28 indexed citations
6.
Blaise, Benjamin J., Cécile Vercherat, Mathilde Bayet‐Robert, et al.. (2013). Metabolic expressivity of human genetic variants: NMR metabotyping of MEN1 pathogenic mutants. Journal of Pharmaceutical and Biomedical Analysis. 93. 118–124. 4 indexed citations
7.
Mahammedi, Hakim, E. Planchat, H. Curé, et al.. (2011). Pilot phase II study with docetaxel in combination with curcuminoids in patients with hormone-resistant prostate cancer (HRPC).. Journal of Clinical Oncology. 29(15_suppl). e15069–e15069. 1 indexed citations
8.
Bayet‐Robert, Mathilde, et al.. (2010). Possible Benefits of Curcumin Regimen in Combination With Taxane Chemotherapy for Hormone-Refractory Prostate Cancer Treatment. Nutrition and Cancer. 62(2). 148–153. 19 indexed citations
9.
Bayet‐Robert, Mathilde, Dominique Loiseau, Pascale Rio, et al.. (2010). Quantitative two‐dimensional HRMAS 1H‐NMR spectroscopy‐based metabolite profiling of human cancer cell lines and response to chemotherapy. Magnetic Resonance in Medicine. 63(5). 1172–1183. 44 indexed citations
10.
Bayet‐Robert, Mathilde, et al.. (2010). Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics. Biochemical Pharmacology. 80(8). 1170–1179. 27 indexed citations
11.
Bayet‐Robert, Mathilde, Marianne Leheurteur, E. Planchat, et al.. (2010). Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biology & Therapy. 9(1). 8–14. 297 indexed citations
12.
Bayet‐Robert, Mathilde, Daniel Morvan, P. Chollet, & Chantal Barthomeuf. (2009). Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses. Breast Cancer Research and Treatment. 120(3). 613–626. 37 indexed citations
13.
Leheurteur, Marianne, Xavier Durando, Marie‐Ange Mouret‐Reynier, et al.. (2009). Metastatic Breast Cancer: Overall Survival Related to Successive Chemotherapies. What Do We Gain After the Third Line?. Cancer Investigation. 27(1). 81–85. 17 indexed citations
14.
Mousseau, Mireille, Henri Faure, Isabelle Hininger‐Favier, Mathilde Bayet‐Robert, & Alain Favier. (2005). Leukocyte 8-oxo-7,8-dihydro-2′-deoxyguanosine and comet assay in epirubicin-treated patients. Free Radical Research. 39(8). 837–843. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026